Literature DB >> 25192506

Genetic cerebellar ataxias.

Elsdon Storey1.   

Abstract

This review broadly covers the commoner genetic ataxias, concentrating on their clinical features. Over the last two decades there has been a potentially bewildering profusion of newly described genetic ataxias. However, at least half of dominant ataxias (SCAs) are caused by (CAG)n repeat expansions resulting in expanded polyglutamine tracts (SCAs 1, 2, 3, 6, 7, 17, and DRPLA), although of the remainder only SCAs 8, 10, 12, 14, 15/16, and 31 are frequent enough that the described phenotype is probably representative. Though the SCAs can be difficult to separate clinically, variations in prevalence in different populations, together with various clinical and radiological features, at least help to order the pretest probabilities. The X-linked disorder, fragile-X tremor ataxia syndrome occurs in fragile-X permutation carriers, and typically causes a late-onset ataxia-plus syndrome. The recessive ataxias are not named systematically: The most frequent are Friedreich, ataxia telangiectasia, ARSACS, AOA1 and 2, and the various POLG syndromes. Although rare, several other recessive disorders such as AVED are potentially treatable and should not be missed. Another group of genetic ataxias are the dominant episodic ataxias, of which EA1 and EA2 are the most important. Lastly, the neurologist's role in ongoing management, rather than just diagnosis, is addressed. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 25192506     DOI: 10.1055/s-0034-1386766

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  22 in total

Review 1.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

Review 2.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

3.  Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.

Authors:  Kenneth W Drombosky; Sascha Rode; Ravi Kodali; Tija C Jacob; Michael J Palladino; Ronald Wetzel
Journal:  Neurobiol Dis       Date:  2018-08-30       Impact factor: 5.996

4.  Disruptive SCYL1 Mutations Underlie a Syndrome Characterized by Recurrent Episodes of Liver Failure, Peripheral Neuropathy, Cerebellar Atrophy, and Ataxia.

Authors:  Wolfgang M Schmidt; S Lane Rutledge; Rebecca Schüle; Benjamin Mayerhofer; Stephan Züchner; Eugen Boltshauser; Reginald E Bittner
Journal:  Am J Hum Genet       Date:  2015-11-12       Impact factor: 11.025

5.  Phenotypic and Genotypic Analysis of Hereditary Ataxia Patients in Sakarya City, Turkey.

Authors:  Saadet Sayan; Dilcan Kotan; Aslı Gündoğdu-Eken; Irmak Şahbaz; Cemile Koçoğlu; A Nazlı Başak
Journal:  Noro Psikiyatr Ars       Date:  2018-07-11       Impact factor: 1.339

6.  Cerebellar tDCS as Therapy for Cerebellar Ataxias.

Authors:  Natale Maiorana; Matteo Guidetti; Michelangelo Dini; Alberto Priori; Roberta Ferrucci
Journal:  Cerebellum       Date:  2022-01-21       Impact factor: 3.648

Review 7.  Hereditary Cerebellar Ataxias: A Korean Perspective.

Authors:  Ji Sun Kim; Jin Whan Cho
Journal:  J Mov Disord       Date:  2015-05-31

8.  Genomic analysis reveals hidden biodiversity within colugos, the sister group to primates.

Authors:  Victor C Mason; Gang Li; Patrick Minx; Jürgen Schmitz; Gennady Churakov; Liliya Doronina; Amanda D Melin; Nathaniel J Dominy; Norman T-L Lim; Mark S Springer; Richard K Wilson; Wesley C Warren; Kristofer M Helgen; William J Murphy
Journal:  Sci Adv       Date:  2016-08-10       Impact factor: 14.136

9.  DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases.

Authors:  Conceição Bettencourt; Davina Hensman-Moss; Michael Flower; Sarah Wiethoff; Alexis Brice; Cyril Goizet; Giovanni Stevanin; Georgios Koutsis; Georgia Karadima; Marios Panas; Petra Yescas-Gómez; Lizbeth Esmeralda García-Velázquez; María Elisa Alonso-Vilatela; Manuela Lima; Mafalda Raposo; Bryan Traynor; Mary Sweeney; Nicholas Wood; Paola Giunti; Alexandra Durr; Peter Holmans; Henry Houlden; Sarah J Tabrizi; Lesley Jones
Journal:  Ann Neurol       Date:  2016-05-06       Impact factor: 10.422

10.  A Novel APTX Variant and Ataxia with Oculomotor Apraxia Type 1.

Authors:  Humera Manzoor; Ihtisham Bukhari; Muhammad Wajid; Yuanwei Zhang; Huan Zhang; Norbert Brüggemann; Christine Klein; Qinghua Shi; Sadaf Naz
Journal:  J Clin Neurol       Date:  2017-05-15       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.